Odyssey Health (ODYY) Total Non-Current Liabilities (2019 - 2026)
Odyssey Health (ODYY) posted quarterly Total Non-Current Liabilities of -$2.1 million for Q2 2026, up 36.02% quarter-over-quarter from -$3.2 million in Q1 2026.
Odyssey Health (ODYY) Total Non-Current Liabilities (2019 - 2026) Analysis & Trends
Odyssey Health's Total Non-Current Liabilities history runs 4 years deep, the most recent figure standing at -$2.1 million for Q2 2026.
- In Q2 2026, Total Non-Current Liabilities changed N/A year-over-year to -$2.1 million; the TTM figure through Apr 2026 stood at -$2.1 million (changed N/A YoY), while the FY2025 annual figure was $49723.0, changed N/A from the prior year.
- Total Non-Current Liabilities for Q2 2026 stood at -$2.1 million, up from -$3.2 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $49723.0 in Q3 2025, with the low at -$3.2 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | - |
| 2 | Stryker | 126.77 Bn | 123.30 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 52.05 Bn | 47.80 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.35 Bn | 32.40 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - | -2.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -2.06 Mn |
| Jan 31, 2026 | -3.21 Mn |
| Oct 31, 2025 | -81,533.00 |
| Jul 31, 2025 | 49,723.00 |
| Apr 30, 2020 | 1.36 Mn |
| Jan 31, 2020 | 1.19 Mn |
| Oct 31, 2019 | 1.07 Mn |
| Jul 31, 2019 | 986,203.00 |